Company Analysis Nuvation Bio Inc.
1. Summary
Advantages
- The stock's return over the last year (47.37%) is higher than the sector average (-31.87%).
- The company's current efficiency (ROE=-12.53%) is higher than the sector average (ROE=-80.86%)
Disadvantages
- Price (2.78 $) is higher than fair price (2.46 $)
- Dividends (0%) are below the sector average (1.32%).
- Current debt level 0.6447% has increased over 5 years from 0%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Nuvation Bio Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0.4% | -2.2% | -2.6% |
| 90 days | 14% | -33.2% | -0.6% |
| 1 year | 47.4% | -31.9% | 16.9% |
NUVB vs Sector: Nuvation Bio Inc. has outperformed the "Healthcare" sector by 79.23% over the past year.
NUVB vs Market: Nuvation Bio Inc. has outperformed the market by 30.43% over the past year.
Stable price: NUVB is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: NUVB with weekly volatility of 0.9109% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (2.78 $) is higher than the fair price (2.46 $).
Price is higher than fair: The current price (2.78 $) is 11.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (114.5).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (70.26).
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.539) is lower than that of the sector as a whole (9.44).
P/BV vs Market: The company's P/BV (0.539) is lower than that of the market as a whole (22.61).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (-421.42) is lower than that of the sector as a whole (4.13).
P/S vs Market: The company's P/S indicator (-421.42) is lower than that of the market as a whole (15.24).
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-2.89) is lower than that of the sector as a whole (17.79).
EV/Ebitda vs Market: The company's EV/Ebitda (-2.89) is lower than that of the market as a whole (24.37).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 16.1% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (16.1%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-57.12%).
5.4. ROE
ROE vs Sector: The company's ROE (-12.53%) is higher than that of the sector as a whole (-80.86%).
ROE vs Market: The company's ROE (-12.53%) is lower than that of the market as a whole (18.07%).
5.5. ROA
ROA vs Sector: The company's ROA (-12.2%) is lower than that of the sector as a whole (6.71%).
ROA vs Market: The company's ROA (-12.2%) is lower than that of the market as a whole (6.49%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-11.88%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (-11.88%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.32%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
